![]() Food and Drug Administration (FDA) cleared its next-generation FreeStyle Libre 3 system for use by people four years and older 6 living with diabetes. 3,4ĪBBOTT PARK, Ill., /PRNewswire/ - Abbott (NYSE: ABT) today announced the U.S. 2ĭesigned for access and affordability, the FreeStyle Libre 3 system will be available at the same price as previous versions, which is one-third the cost of other competing continuous glucose monitoring systems available today. The FreeStyle Libre 3 system is the most accurate 14-day continuous glucose monitor 1, with readings sent directly to a smartphone every minute. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |